Sigilon Therapeutics, Inc. (SGTX) has 4 open-market insider trades by 4 insiders since 2020. The most active filer is Shenandoah Acquisition Corp, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Shenandoah Acquisition Corp | 10% Owner | — | 1 | $51.3M | 2023-08-11 |
| Lilly & Co Eli | 10% Owner | — | 1 | $5.4M | 2020-12-08 |
| Daniel Griffith Anderson | Dir | — | 1 | $2.0M | 2021-06-02 |
| Robert R. Ruffolo | Dir | — | 1 | $70K | 2021-07-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Shenandoah Acquisition Corp | 10% Owner | Buy | $51.3M | 2023-08-11 |
| Robert R. Ruffolo | Director | Sell | $70K | 2021-07-01 |
| Daniel Griffith Anderson | Director | Sell | $2.0M | 2021-06-02 |
| Lilly & Co Eli | 10% Owner | Buy | $5.4M | 2020-12-08 |
Companies that share insiders with SGTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.